Skip to content

Postnatal modulation of body composition in preterm infants by human growth factors and hormones in relation to various nutrient compositions.

Postnatal modulation of body composition in preterm infants by human growth factors and hormones in relation to various nutrient compositions. - NUTRIE study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47744
Enrollment
170
Registered
2015-02-03
Start date
2015-09-29
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensie cardiovascular diseases/heart disease risk factors for diabetes mellitus/diabetes

Interventions

Infants will be randomized to either preterm follow-up formula or standard care at a postmenstrual age of 32-33 weeks.

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: 1. Written and informed consent from either the parents or the legal guardians who at least have professional working proficiency of the Dutch, English or French language. 2. Gestational age of 24 to 32 weeks. 3. Arterial catheter in situ.;In order to be eligible for cord blood analysis, a subject must meet all of the following criteria: 1. Gestational age of 24 to 42 weeks 2. Written and informed consent from either the parents or the legal guardians who at least have professional working proficiency of the Dutch, English or French language.

Exclusion criteria

Exclusion criteria: A substantial congenital anomaly based on a chromosomal or syndromal disorder with a known effect on growth and body composition.

Design outcomes

Primary

MeasureTime frame
The main study parameters are anthropometry (height, weight and body proportions), body composition and growth-related endocrine parameters.

Secondary

MeasureTime frame
Psychomotor development, bone mineralization, lipid status and blood pressure

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)